422 related articles for article (PubMed ID: 27034082)
21. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.
Thurber KM; Otto AO; Stricker SL
Am J Health Syst Pharm; 2023 Apr; 80(8):487-494. PubMed ID: 36629265
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.
Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H
Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254
[TBL] [Abstract][Full Text] [Related]
23. [Adverse events associated with long-term use of proton pump inhibitors].
Reimer C; Bytzer P
Ugeskr Laeger; 2012 Sep; 174(39):2289-93. PubMed ID: 23006222
[TBL] [Abstract][Full Text] [Related]
24. Safety of long-term PPI therapy.
Reimer C
Best Pract Res Clin Gastroenterol; 2013 Jun; 27(3):443-54. PubMed ID: 23998981
[TBL] [Abstract][Full Text] [Related]
25. Proton Pump Inhibitors: Review of Emerging Concerns.
Nehra AK; Alexander JA; Loftus CG; Nehra V
Mayo Clin Proc; 2018 Feb; 93(2):240-246. PubMed ID: 29406201
[TBL] [Abstract][Full Text] [Related]
26. [Adverse effects of proton pump inhibitors: should we worry about long-term exposure?].
Roulet L; Vernaz N; Giostra E; Gasche Y; Desmeules J
Rev Med Interne; 2012 Aug; 33(8):439-45. PubMed ID: 22284952
[TBL] [Abstract][Full Text] [Related]
27. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
Dharmarajan TS
J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
[TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitors increase risk of bone fractures in men with cirrhosis: a population-based study.
Labenz C; Wörns MA; Adarkwah CC; Galle PR; Schattenberg JM; Kostev K
Aliment Pharmacol Ther; 2020 Sep; 52(6):1042-1050. PubMed ID: 32729625
[TBL] [Abstract][Full Text] [Related]
29. The association of proton pump inhibitors and hypomagnesemia in the community setting.
Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
[TBL] [Abstract][Full Text] [Related]
30. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
[TBL] [Abstract][Full Text] [Related]
31. Safety of the long-term use of proton pump inhibitors.
Thomson AB; Sauve MD; Kassam N; Kamitakahara H
World J Gastroenterol; 2010 May; 16(19):2323-30. PubMed ID: 20480516
[TBL] [Abstract][Full Text] [Related]
32. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities.
Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T
J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000
[TBL] [Abstract][Full Text] [Related]
33. Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study.
Hess MW; de Baaij JH; Broekman MM; Bisseling TM; Haarhuis BJ; Tan AC; Te Morsche RH; Hoenderop JG; Bindels RJ; Drenth JP
Pharmacogenet Genomics; 2017 Mar; 27(3):83-88. PubMed ID: 27926584
[TBL] [Abstract][Full Text] [Related]
34. Hypomagnesemia and proton-pump inhibitors.
Famularo G; Gasbarrone L; Minisola G
Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular and non-cardiovascular concerns with proton pump inhibitors: Are they safe?
Corsonello A; Lattanzio F
Trends Cardiovasc Med; 2019 Aug; 29(6):353-360. PubMed ID: 30389278
[TBL] [Abstract][Full Text] [Related]
36. Indications and safety of proton pump inhibitor drug use in patients with cancer.
Triadafilopoulos G; Roorda AK; Akiyama J
Expert Opin Drug Saf; 2013 Sep; 12(5):659-72. PubMed ID: 23647006
[TBL] [Abstract][Full Text] [Related]
37. [Severe hypomagnesaemia due to proton pump inhibitor use].
van den Berg S; Scheer MLJ; Holman ND
Ned Tijdschr Geneeskd; 2018 Aug; 162():. PubMed ID: 30182626
[TBL] [Abstract][Full Text] [Related]
38. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
[TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitors--uncommon adverse effects.
Oh S
Aust Fam Physician; 2011 Sep; 40(9):705-8. PubMed ID: 21894279
[TBL] [Abstract][Full Text] [Related]
40. Serum magnesium and proton-pump inhibitors use: a cross-sectional study.
Faulhaber GA; Ascoli BM; Lubini A; Mossmann M; Rossi G; Geib G; Furlanetto TW
Rev Assoc Med Bras (1992); 2013; 59(3):276-9. PubMed ID: 23680271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]